Why'd companies report so late?
It has been reported that the big pharmaceutical companies Merck and Schering-Plough reported that the popular cholesterol lowering drug Zetia (and a pill that contains it, Vitoryn) "failed to slow the buildup of artery-clogging plaque, raising questions about its use."
They got the results of their two-year trial in April of 2006, yet for some reason missed their own deadlines for reporting their findings.
Perhaps they were concerned with the adverse side affects -- like losing hundreds of millions of dollars for selling a useless drug.
That would certainly cut into their available funds to lobby Congress for even more favorable laws to keep drug prices high, wouldn't it?
Ken Glassman
Arlington Heights
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.